Journal Home
Search for

Articles in Press

Return to articles in press list

Bioavailability of marine n-3 fatty acid formulations

J. DyerbergaCorresponding Author Informationemail address, P. Madsenb, J.M. Møllerc, I. Aardestrupb, E.B. Schmidtd

Received 3 March 2010; received in revised form 28 June 2010; accepted 29 June 2010. published online 21 July 2010.
Corrected Proof

Abstract 

The use of marine n-3 polyunsaturated fatty acids (n-3 PUFA) as supplements has prompted the development of concentrated formulations to overcome compliance problems. The present study compares three concentrated preparations — ethyl esters, free fatty acids and re-esterified triglycerides — with placebo oil in a double-blinded design, and with fish body oil and cod liver oil in single-blinded arms. Seventy-two volunteers were given approximately 3.3g of eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) daily for 2 weeks. Increases in absolute amounts of EPA and DHA in fasting serum triglycerides, cholesterol esters and phospholipids were examined. Bioavailability of EPA+DHA from re-esterified triglycerides was superior (124%) compared with natural fish oil, whereas the bioavailability from ethyl esters was inferior (73%). Free fatty acid bioavailability (91%) did not differ significantly from natural triglycerides. The stereochemistry of fatty acid in acylglycerols did not influence the bioavailability of EPA and DHA.

a Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen, Copenhagen, Denmark

b Department of Clinical Biochemistry, Center for Cardiovascular Research Aalborg Hospital, Aalborg, Denmark

c Department of Gastroenterology, Aalborg Hospital, Aalborg, Denmark

d Department of Cardiology, Center for Cardiovascular Research Aalborg Hospital, Aalborg, Denmark

Corresponding Author InformationCorrespondence to: Lille Fredensvej 6A, DK 2920, Charlottenlund, Denmark. Tel.: +4539636688; fax: +4539636689.

 The main results have been previously published in the proceedings of a workshop at the 29th yearly meeting of The European Society for Clinical Investigation: n-3 Fatty acids: prevention and treatment in vascular disease. S.D. Kristensen, E.B. Schmidt, R. de Caterina, S. Endres (Eds). Springer Verlag, London, 1995

PII: S0952-3278(10)00117-1

doi:10.1016/j.plefa.2010.06.007